pharma
The Top Business Acquisitions to Watch in 2026
After two years of market turbulence, regulatory uncertainty, and elevated interest rates, the M&A market is expected to roar back. Private equity firms are sitting
From FDA to Big Pharma: The Revolving Door Phenomenon
Recent statistics reveal a troubling trend in American healthcare regulation. Nine out of ten FDA commissioners moved to pharmaceutical companies between 2006 and 2019. This